Front Pharmacol 21(9):557 Siriwardhana N, Kalupahana NS, Moustaid-Moussa N (2012) Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid
This glucagon-like peptide-1 (GLP-1) medication imitates a hormone the body produces during food consumption
Personalized Medical Weight Loss Solutions Designed for Real, Lasting Results Our medical weight loss program is built on a foundation of clinical insight, hormone support, and personalized treatment, not fad diets or one-size-fits-all strategies
One vodka soda per week adds roughly 5,000 calories per year
Back to Journals Drug Design, Development and Therapy Volume 19 Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study Received 1 April 2025 Accepted for publication 25 June 2025 Published 3 July 2025 Volume 2025:19 Pages 56455652 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Dr Tuo Deng Qingjuan Ren, Lei Zhi, Hongfang Liu Department of Geriatrics, Shijiazhuang Peoples Hospital, Shijiazhuang, Hebei, Peoples Republic of China Correspondence: Qingjuan Ren, Department of Geriatrics, Shijiazhuang Peoples Hospital, Shijiazhuang, Hebei, Peoples Republic of China, Email [email protected] Purpose: This study aimed to investigate changes in muscle mass and strength among older adults with type 2 diabetes who were treated with Semaglutide